Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 45,257 | 40,033 | 38,686 | 31,655 | 26,305 |
| Operating Income | -45,257 | -40,033 | -38,686 | -31,655 | -26,305 |
| Other Income | 2,903 | 434 | -783 | 2,517 | -3,485 |
| Pre-tax Income | -42,354 | -39,599 | -39,469 | -29,138 | -29,790 |
| Income Tax | 31 | -202 | -186 | 212 | -442 |
| Net Income Continuous | -42,385 | -39,397 | -39,283 | -29,350 | -29,348 |
| Net Income | $-42,385 | $-39,397 | $-39,283 | $-29,350 | $-29,348 |
| EPS Basic Total Ops | -0.47 | -0.44 | 0.76 | -1.61 | -1.76 |
| EPS Basic Continuous Ops | -0.47 | -0.44 | 0.43 | -1.32 | -1.45 |
| EPS Diluted Total Ops | -0.47 | -0.44 | 0.76 | -1.61 | -1.76 |
| EPS Diluted Continuous Ops | -0.47 | -0.44 | 0.43 | -1.32 | -1.45 |
| EBITDA(a) | $-44,931 | $-39,592 | $-38,166 | $-31,173 | $-25,819 |